Aclaris Therapeutics, Inc. (ACRS)
3.75
-0.08
(-2.09%)
USD |
NASDAQ |
Oct 23, 16:00
3.755
0.00 (0.00%)
After-Hours: 20:00
Aclaris Therapeutics Price to Book Value : 4.209 for Oct. 23, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 4.209 |
| October 22, 2026 | 4.299 |
| October 21, 2026 | 4.276 |
| October 20, 2026 | 4.231 |
| October 19, 2026 | 3.906 |
| October 16, 2026 | 3.681 |
| October 15, 2026 | 3.917 |
| October 14, 2026 | 3.794 |
| October 13, 2026 | 3.895 |
| October 12, 2026 | 4.040 |
| October 09, 2026 | 4.299 |
| October 08, 2026 | 4.254 |
| October 07, 2026 | 3.816 |
| October 06, 2026 | 4.153 |
| October 05, 2026 | 4.792 |
| October 02, 2026 | 4.927 |
| October 01, 2026 | 4.950 |
| September 30, 2026 | 5.904 |
| September 29, 2026 | 5.926 |
| September 28, 2026 | 6.094 |
| September 25, 2026 | 5.780 |
| September 24, 2026 | 6.038 |
| September 23, 2026 | 5.904 |
| September 22, 2026 | 6.420 |
| September 21, 2026 | 6.252 |
| Date | Value |
|---|---|
| September 18, 2026 | 6.173 |
| September 17, 2026 | 6.061 |
| September 16, 2026 | 5.971 |
| September 15, 2026 | 6.201 |
| September 14, 2026 | 6.330 |
| September 11, 2026 | 5.971 |
| September 10, 2026 | 6.179 |
| September 09, 2026 | 6.240 |
| September 08, 2026 | 6.802 |
| September 04, 2026 | 6.925 |
| September 03, 2026 | 6.678 |
| September 02, 2026 | 6.936 |
| September 01, 2026 | 6.757 |
| August 31, 2026 | 6.790 |
| August 28, 2026 | 6.745 |
| August 27, 2026 | 6.914 |
| August 26, 2026 | 6.947 |
| August 25, 2026 | 7.335 |
| August 24, 2026 | 7.082 |
| August 21, 2026 | 7.194 |
| August 20, 2026 | 7.104 |
| August 19, 2026 | 7.228 |
| August 18, 2026 | 7.076 |
| August 17, 2026 | 6.644 |
| August 14, 2026 | 6.487 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Corcept Therapeutics, Inc. | 13.13 |
| Alumis, Inc. | 1.927 |
| ANI Pharmaceuticals, Inc. | 2.793 |
| Veru, Inc. | 1.346 |
| Johnson & Johnson | 7.789 |
Price to Book Value Related Metrics
| PS Ratio | 58.95 |
| Price | 3.75 |
| Earnings Yield | -15.61% |
| Market Cap | 524.34M |